BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 22697592)

  • 1. Strategies to decrease ongoing oxidant burden in chronic obstructive pulmonary disease.
    Rahman I; Kinnula VL
    Expert Rev Clin Pharmacol; 2012 May; 5(3):293-309. PubMed ID: 22697592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological and dietary antioxidant therapies for chronic obstructive pulmonary disease.
    Biswas S; Hwang JW; Kirkham PA; Rahman I
    Curr Med Chem; 2013; 20(12):1496-530. PubMed ID: 22963552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antioxidant therapies in COPD.
    Rahman I
    Int J Chron Obstruct Pulmon Dis; 2006; 1(1):15-29. PubMed ID: 18046899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease.
    MacNee W
    Proc Am Thorac Soc; 2005; 2(1):50-60. PubMed ID: 16113469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antioxidant therapeutic advances in COPD.
    Rahman I
    Ther Adv Respir Dis; 2008 Dec; 2(6):351-74. PubMed ID: 19124382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antioxidant therapeutic targets in COPD.
    Rahman I; Kilty I
    Curr Drug Targets; 2006 Jun; 7(6):707-20. PubMed ID: 16787173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidants and COPD.
    MacNee W
    Curr Drug Targets Inflamm Allergy; 2005 Dec; 4(6):627-41. PubMed ID: 17305519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current perspectives of oxidative stress and its measurement in chronic obstructive pulmonary disease.
    Lin JL; Thomas PS
    COPD; 2010 Aug; 7(4):291-306. PubMed ID: 20673039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COPD: balancing oxidants and antioxidants.
    Fischer BM; Voynow JA; Ghio AJ
    Int J Chron Obstruct Pulmon Dis; 2015; 10():261-76. PubMed ID: 25673984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic Potential of Small Molecules Targeting Oxidative Stress in the Treatment of Chronic Obstructive Pulmonary Disease (COPD): A Comprehensive Review.
    Dailah HG
    Molecules; 2022 Aug; 27(17):. PubMed ID: 36080309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological antioxidant strategies as therapeutic interventions for COPD.
    Rahman I
    Biochim Biophys Acta; 2012 May; 1822(5):714-28. PubMed ID: 22101076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of oxidant/antioxidant balance in COPD and non-COPD smokers.
    Aydemir Y; Aydemir Ö; Şengül A; Güngen AC; Çoban H; Taşdemir C; Düzenli H; Şehitoğulları A
    Heart Lung; 2019; 48(6):566-569. PubMed ID: 31371032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Markers of anti-oxidant response in tobacco smoke exposed subjects: a data-mining review.
    Comandini A; Marzano V; Curradi G; Federici G; Urbani A; Saltini C
    Pulm Pharmacol Ther; 2010 Dec; 23(6):482-92. PubMed ID: 20594977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress and antioxidant enzyme activity in South Indian male smokers with chronic obstructive pulmonary disease.
    Arja C; Surapaneni KM; Raya P; Adimoolam C; Balisetty B; Kanala KR
    Respirology; 2013 Oct; 18(7):1069-75. PubMed ID: 23683270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update in chronic obstructive pulmonary disease: role of antioxidant and metabolizing gene polymorphisms.
    Lakhdar R; Denden S; Kassab A; Leban N; Knani J; Lefranc G; Miled A; Chibani JB; Khelil AH
    Exp Lung Res; 2011 Aug; 37(6):364-75. PubMed ID: 21721950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decline in NRF2-regulated antioxidants in chronic obstructive pulmonary disease lungs due to loss of its positive regulator, DJ-1.
    Malhotra D; Thimmulappa R; Navas-Acien A; Sandford A; Elliott M; Singh A; Chen L; Zhuang X; Hogg J; Pare P; Tuder RM; Biswal S
    Am J Respir Crit Care Med; 2008 Sep; 178(6):592-604. PubMed ID: 18556627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antioxidant pharmacological therapies for COPD.
    Rahman I; MacNee W
    Curr Opin Pharmacol; 2012 Jun; 12(3):256-65. PubMed ID: 22349417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidants/antioxidants and COPD.
    MacNee W
    Chest; 2000 May; 117(5 Suppl 1):303S-17S. PubMed ID: 10843965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current concepts on oxidative/carbonyl stress, inflammation and epigenetics in pathogenesis of chronic obstructive pulmonary disease.
    Yao H; Rahman I
    Toxicol Appl Pharmacol; 2011 Jul; 254(2):72-85. PubMed ID: 21296096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative stress and free radicals in COPD--implications and relevance for treatment.
    Domej W; Oettl K; Renner W
    Int J Chron Obstruct Pulmon Dis; 2014; 9():1207-24. PubMed ID: 25378921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.